Vimarsana
Biggest News Aggregation in the World

Page 26 - Technology Access Pool News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technology Access Pool. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technology Access Pool Today - Breaking & Trending Today

Global deal to provide COVID antibody test tech free to poorer countries - Vimarsana News

Global deal to provide COVID antibody test tech free to poorer countries

A global licence for serological technology that detects COVID-19 antibodies will be provided royalty-free to poor and low-income countries

Source: arynews.tv
WHO and MPP announce first transparent, global, non-exclusive licence for Covid technology - Vimarsana News

WHO and MPP announce first transparent, global, non-exclusive licence for Covid technology

WHO’s COVID-19 Technology Access Pool (C-TAP) and the Medicines Patent Pool (MPP) today finalized a licensing agreement with the Spanish National

Global licence deal to provide Covid antibody test tech free to poorer countries: WHO - Vimarsana News

Global licence deal to provide Covid antibody test tech free to poorer countries: WHO

The existing four tests, which check for the presence of SARS-CoV-2 antibodies developed after either an infection or a vaccine dose, could also inform decisions on the need for boosters to protect against the disease.

WHO's C-TAP and MPP finalize licensing agreement with CSIC for COVID-19 serological antibody technology - Vimarsana News

WHO's C-TAP and MPP finalize licensing agreement with CSIC for COVID-19 serological antibody technology

WHO's COVID-19 Technology Access Pool and the Medicines Patent Pool today finalized a licensing agreement with the Spanish National Research Council for a COVID-19 serological antibody technology.

How financial shortfalls hold back HIV response in Africa - Vimarsana News

How financial shortfalls hold back HIV response in Africa

According to the latest figures from Joint United Nations Programme on AIDS (UNAIDS), underinvestment in the Human Immuno-deficiency Virus (HIV) responses of low- and middle-income countries